scholarly journals Acute-onset Autoimmune Hepatitis in a Young Woman with Type 1 Diabetes Mellitus

2018 ◽  
Vol 57 (11) ◽  
pp. 1591-1596 ◽  
Author(s):  
Satoshi Takai ◽  
Jun Inoue ◽  
Takayuki Kogure ◽  
Eiji Kakazu ◽  
Masashi Ninomiya ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Autoimmune Hepatitis ◽  
Young Woman ◽  
Acute Onset

scholarly journals CD4+ T cell-dominant insulitis in acute-onset Type 1 diabetes mellitus associated with intraductal papillary mucinous adenoma

2016 ◽  
Vol 63 (9) ◽  
pp. 841-847
Author(s):  
Ken Yajima ◽  
Yoichi Oikawa ◽  
Kentaro Ogata ◽  
Akinori Hashiguchi ◽  
Akira Shimada
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
T Cell ◽  
Type 1 Diabetes Mellitus ◽  
Acute Onset ◽  
Onset Type

scholarly journals Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus

2014 ◽  
Vol 17 (1) ◽  
pp. 29-33
Author(s):  
Olga Sergeevna Derevyanko ◽  
Nadejda Sergeevna Dalantaeva ◽  
Olga Nikolaevna Ivanova ◽  
Nikolay Petrovich Goncharov ◽  
Tatiana Vasil'evna Nikonova ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Autoimmune Hepatitis ◽  
Clinical Features ◽  
Autoimmune Disorders ◽  
Diagnostic Methods

Aim. To assess the occurrence of autoantibodies characteristic of autoimmune hepatitis in patients with type 1 diabetes mellitus (T1DM), and to analyze clinical features of positive subjects. Materials and Methods. . 84 patients (39 male, 45 female) with T1DM were subdivided into two groups and underwent biochemical, immunologic and instrumental examination. Results. Markers for hepatic autoimmune disorders were found to be highly prevalent in patients with T1DM, even in those asymptomatic according to clinical and instrumental diagnostic methods. Conclusion.  Our data suggests that T1DM patients are at higher risk of corresponding, though possibly asymptomatic autoimmune disorders.

Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report

2018 ◽  
Vol 25 (8) ◽  
pp. 2023-2026 ◽  
Author(s):  
Yukihisa Hatakeyama ◽  
Hisashi Ohnishi ◽  
Kentaro Suda ◽  
Kayoko Okamura ◽  
Temiko Shimada ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Adverse Event ◽  
Type 1 Diabetes Mellitus ◽  
Acute Onset ◽  
Thyroid Peroxidase ◽  
Family History Of Diabetes ◽  
Onset Type ◽  
Related Adverse Event

A 60-year-old Japanese man, with no medical or family history of diabetes, presented with acute-onset type 1 diabetes following nivolumab treatment for advanced non-small-cell lung cancer. During cycle 35 of nivolumab therapy, his glycated hemoglobin level increased from 7.6% to 9.1% in one month. Test results for islet-related and anti-thyroid peroxidase antibodies were negative. A glucagon tolerance test showed insulin dependency. Type 1 diabetes after anti-programmed death-ligand 1 antibody administration is an immune-related adverse event, and numerous reports suggest that fulminant type 1 diabetes can develop in these patients. However, there are few reports of acute-onset type 1 diabetes mellitus.

Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012)

2013 ◽  
Vol 4 (4) ◽  
pp. 221-225 ◽  
Author(s):  
Eiji Kawasaki ◽  
Taro Maruyama ◽  
Akihisa Imagawa ◽  
Takuya Awata ◽  
Hiroshi Ikegami ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Diagnostic Criteria ◽  
Acute Onset ◽  
Onset Type

scholarly journals Acute-onset type 1 diabetes mellitus caused by nivolumab in a patient with advanced pulmonary adenocarcinoma

2017 ◽  
Vol 8 (6) ◽  
pp. 798-799 ◽  
Author(s):  
Ryo Kumagai ◽  
Aiko Muramatsu ◽  
Rikako Nakajima ◽  
Masanao Fujii ◽  
Kenta Kaino ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Acute Onset ◽  
Pulmonary Adenocarcinoma ◽  
Onset Type
Sign in / Sign up

Export Citation Format

Share Document